Correction to “Stereoselective Synthesis of Nucleotide Analog Prodrugs (ProTides) via an Oxazaphospholidine Method”

Entries 1–3 and Entry 4 were conducted on 0.03 and 0.18 mmol scales, respectively. Entry 1: Determined from the ³¹P NMR spectrum of crude mixture. Entries 2 and 3: Determined from the ³¹P NMR spectra after purification. Entry 4 was determined from RP-HPLC after deprotection of the DMTr group of the model compound. All reagents were added as CH₃CN solution. (Sp)-4b and (Rp)-4b were used in Entries 1–3 and Entry 4, respectively. Determined from the ³¹P NMR spectra of crude mixtures. Determined from the ³¹P NMR spectra of crude mixtures. Extraction in 0.2 M citric acid aqueous solution. Determined from the ³¹P NMR spectra after purification. Determined from the ³¹P NMR spectra of crude mixtures. Determined from the ³¹P NMR spectra after purification. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.joc.5c02213. Experimental details, HPLC profiles, copies of ¹H, ¹³C, and ³¹P NMR spectra of new compounds and final products (corrected) (PDF) Correction to “Stereoselective Synthesis of Nucleotide Analog Prodrugs (ProTides) via an Oxazaphospholidine Method” 3 views 0 shares 0 downloads Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html. This article has not yet been cited by other publications.